Truist Securities analyst Kaila Krum raised the price target on Integra LifeSciences (NASDAQ: IART) to $75.00 (from $70.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Integra LifeSciences (IART) Tops Q4 EPS by 11c; Offers 1Q EPS/Revenue Guidance Below Consensus, FY21 Revenues Views Below ConsensusFebruary 18, 2021 6:26 AM Form 8-K INTEGRA LIFESCIENCES For: Feb 18February 18, 2021 6:16 AM Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial GuidanceFebruary 18, 2021 6:00 AM Form 4 INTEGRA LIFESCIENCES For: Feb 13 Filed by: BRADLEY KEITHFebruary 16, 2021 4:21 PM Form SC 13G/A INTEGRA LIFESCIENCES Filed by: Capital Research Global InvestorsFebruary 16, 2021 3:13 PM Form SC 13G/A INTEGRA LIFESCIENCES Filed by: Tru St Partnership, L.P.February 16, 2021 9:04 AM